Literature DB >> 2448062

Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities.

L Lundin1, I Norheim, J Landelius, K Oberg, E Theodorsson-Norheim.   

Abstract

Cardiac ultrasound investigation of 68 prospectively studied patients with histologically proven midgut carcinoid tumors showed right heart disease in 66%. The abnormal findings included morphologic and functional aberrations of the tricuspid valve in 52% and 83%, respectively, right atrial and ventricular enlargement in 53% and 30%, and paradoxical systolic septal contractions in 19%. The patients with the most pronounced right heart disease had significantly higher (p less than .01) plasma levels of the tachykinins neuropeptide K and substance P as well as higher (p less than .001) urinary excretion of the serotonin metabolite 5-hydroxyindoleacetic acid. These patients also had the most extensive tumor disease. The occurrence of echocardiographic abnormalities of the left heart was similar to that in healthy individuals of the same age, but abnormalities were less frequent among the patients with severe right heart disease. Electrocardiographic changes were nonspecific. Right heart disease thus seems to be present more often than previously reported in patients with malignant midgut carcinoid tumors. The severity of cardiac involvement does not seem to be related to the duration of carcinoid disease but more to the extent of the disease, i.e., higher plasma levels of serotonin and tachykinins.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2448062     DOI: 10.1161/01.cir.77.2.264

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  36 in total

1.  Ovarian tumor-associated carcinoid heart disease presenting as severe tricuspid regurgitation.

Authors:  Hong-Won Shin; Hyungseop Kim; Hyuck-Jun Yoon; Hyoung-Seob Park; Yun-Kyeong Cho; Chang-Wook Nam; Seung-Ho Hur; Yoon-Nyun Kim; Kwon-Bae Kim
Journal:  J Cardiovasc Ultrasound       Date:  2011-03-31

Review 2.  Atrial fibrillation in carcinoid heart disease: The role of serotonin. A review of the literature.

Authors:  C Langer; C Piper; J Vogt; J Heintze; T Butz; O Lindner; W Burchert; C Kersting; D Horstkotte
Journal:  Clin Res Cardiol       Date:  2006-11-24       Impact factor: 5.460

Review 3.  Echocardiography in functional midgut neuroendocrine tumors: When and how often.

Authors:  Javier G Castillo; Tara Naib; Jerome S Zacks; David H Adams
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

Review 4.  Carcinoid Heart Disease: Review of Current Knowledge.

Authors:  Pradhum Ram; Jorge L Penalver; Kevin Bryan U Lo; Janani Rangaswami; Gregg S Pressman
Journal:  Tex Heart Inst J       Date:  2019-02-01

5.  The role of 5-HT2B receptors in mitral valvulopathy: bone marrow mobilization of endothelial progenitors.

Authors:  Estelle Ayme-Dietrich; Roland Lawson; Francine Côté; Claudia de Tapia; Sylvia Da Silva; Claudine Ebel; Béatrice Hechler; Christian Gachet; Jérome Guyonnet; Hélène Rouillard; Jordane Stoltz; Emily Quentin; Sophie Banas; François Daubeuf; Nelly Frossard; Bernard Gasser; Jean-Philippe Mazzucotelli; Olivier Hermine; Luc Maroteaux; Laurent Monassier
Journal:  Br J Pharmacol       Date:  2017-10-15       Impact factor: 8.739

Review 6.  Carcinoid Heart Disease: a Comprehensive Review.

Authors:  Saamir A Hassan; Nicolas L Palaskas; Ali M Agha; Cezar Iliescu; Juan Lopez-Mattei; Christopher Chen; Henry Zheng; Syed Wamique Yusuf
Journal:  Curr Cardiol Rep       Date:  2019-11-19       Impact factor: 2.931

7.  Carcinoid valve disease.

Authors:  J Wells Askew; Heidi M Connolly
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

8.  Bronchial neuroendocrine (carcinoid) tumor causing unilateral left-sided carcinoid heart disease.

Authors:  P Greminger; O M Hess; A E Müller; L von Segesser; J Schneider; G Sütsch; W Siegenthaler; P U Heitz
Journal:  Klin Wochenschr       Date:  1991-02-06

9.  Transoesophageal echocardiography improves the diagnostic value of cardiac ultrasound in patients with carcinoid heart disease.

Authors:  L Lundin; J Landelius; B Andrén; K Oberg
Journal:  Br Heart J       Date:  1990-09

Review 10.  Fibrosis and carcinoid syndrome: from causation to future therapy.

Authors:  Maralyn Druce; Andrea Rockall; Ashley B Grossman
Journal:  Nat Rev Endocrinol       Date:  2009-05       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.